ADC Therapeutics (ADCT) had the highest return between January 22, 2024 and January 30, 2024 by a small-cap US stock, returning 82.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
ADC Therapeutics (ADCT) | 1/22/2024 - 1/30/2024 | 82.39% |
QuantaSing Group Limited American Depositary Shares (QSG) | 1/22/2024 - 1/30/2024 | 66.81% |
Here (HERE) | 1/22/2024 - 1/30/2024 | 66.81% |
Astria Therapeutics (ATXS) | 1/22/2024 - 1/30/2024 | 65.89% |
PepGen (PEPG) | 1/22/2024 - 1/30/2024 | 57.95% |
Dianthus Therapeutics (DNTH) | 1/22/2024 - 1/30/2024 | 43.19% |
Solid Power (SLDP) | 1/22/2024 - 1/30/2024 | 42.61% |
Compass Pathways (CMPS) | 1/22/2024 - 1/30/2024 | 42.59% |
Kura Oncology (KURA) | 1/22/2024 - 1/30/2024 | 40.97% |
Kodiak Sciences (KOD) | 1/22/2024 - 1/30/2024 | 38.73% |
Mercurity Fintech Holding Inc ADR (MFH) | 1/22/2024 - 1/30/2024 | 37.8% |
American Superconductor (AMSC) | 1/22/2024 - 1/30/2024 | 36.72% |
Lexicon Pharmaceuticals (LXRX) | 1/22/2024 - 1/30/2024 | 36.43% |
Larimar Therapeutics (LRMR) | 1/22/2024 - 1/30/2024 | 36.36% |
POET Technologies (POET) | 1/22/2024 - 1/30/2024 | 35.42% |
Immunome (IMNM) | 1/22/2024 - 1/30/2024 | 33.57% |
Trilogy Metals (TMQ) | 1/22/2024 - 1/30/2024 | 33.33% |
GH Research (GHRS) | 1/22/2024 - 1/30/2024 | 33.1% |
Akso Health Group ADR (AHG) | 1/22/2024 - 1/30/2024 | 27.87% |
Purecycle Technologies (PCT) | 1/22/2024 - 1/30/2024 | 27.78% |
iHeartMedia Inc Class A (IHRT) | 1/22/2024 - 1/30/2024 | 27.43% |
Intuitive Machines (LUNR) | 1/22/2024 - 1/30/2024 | 25.46% |
DeFi Development (DFDV) | 1/22/2024 - 1/30/2024 | 24.94% |
Arteris (AIP) | 1/22/2024 - 1/30/2024 | 24.81% |
Cullinan Oncology LLC (CGEM) | 1/22/2024 - 1/30/2024 | 23.82% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
